Bayer invests 2 billion euros in the production of medicines

German drugmaker Bayer said it will invest about 2 billion euros ($2.23 billion) in pharmaceutical manufacturing sites over the next three years, mainly to support the production of biotech drugs, as well as cell and gene therapies.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner